Project Grant HT9425261E131
- Grant Award Summary The Defense Health Agency (DHA), through its Military Medical Research and Development program (CFDA 12.420), awarded a $998,633 Project Grant to the Northern California Institute for Research and Education, Inc. (NCIRE) on September 1, 2026, with a completion date of August 31, 2029. The grant funds research to develop midlife risk factors and risk score models for Alzheimer's Disease and Alzheimer's Disease and Related Dementias (AD/ADRD) among male and female veterans....
- The U.S. Defense Health Agency awarded a $2,916,605 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the Boston VA Research Institute, Inc. (BVARI) on September 30, 2023. The 4-year award, titled "LONG-TERM PSYCHOLOGICAL AND PHYSICAL HEALTH OUTCOMES FOLLOWING MILITARY DEPLOYMENT: THE VETERANS AFTER-DISCHARGE LONGITUDINAL REGISTRY (PROJECT VALOR)", will fund BVARI's research to investigate risk factors, prevention, and...
- Federal Grant Award Summary The Veterans Bio-Medical Research Institute Inc. received a $1.64M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on November 1, 2026, with completion targeted for October 31, 2030. The research initiative focuses on developing and validating time-efficient, high-resistance inspiratory muscle training interventions to address exertional dyspnea in deployed veterans. This research...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Veterans Medical Research Foundation of San Diego a $2,074,865 Project Grant effective September 1, 2025, through August 31, 2029, under the Military Medical Research and Development program (CFDA 12.420). The award funds research to develop machine learning algorithms that utilize pre-intervention supraspinal functional connectivity imaging data to predict patient responsiveness to repetitive transcranial magnetic stimulation...
- Federal Grant Award Summary The Defense Health Agency awarded a $1,155,518 Project Grant to Massachusetts General Hospital (The General Hospital Corporation) under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2028. The award supports research into in vivo neuroepigenetics in combat veterans with repeated blast exposure, addressing a critical military health priority within the Defense Health Agency's portfolio of basic,...
- Federal Grant Award Summary Brigham & Women's Hospital Inc. received a $1.0 million project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on inflammasome control of astrocyte-driven multiple sclerosis pathology. The award, effective September 1, 2025, through August 31, 2028, supports a three-year research initiative investigating the role of inflammasome activation in astrocyte-mediated pathological...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Massachusetts General Hospital (MGH) a $1.35M Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025 through June 30, 2029. The award funds research investigating metabolites and metabolic pathways in relation to Crohn disease risk, with research activities conducted at MGH's Boston, Massachusetts location. This biomedical research initiative aligns with the DHA's...
- Federal Grant Award Summary The Defense Health Agency awarded Columbia University's Health Sciences Division a $301,632 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2026, with completion targeted for July 31, 2029. The project, titled "The Value of Hypertension Control to Prevent Dementia and Enhance Readiness: Generating Evidence from DOD-VHA Data, Patient Preferences and Health Economics," will deliver evidence-based...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded $516,256 to VA Connecticut Research & Education Foundation, Inc. under the Military Medical Research and Development program (CFDA 12.420) for a three-year project beginning April 1, 2026 and concluding March 31, 2029. The award supports comprehensive risk stratification research for hepatocellular carcinoma (HCC) in veterans living with chronic hepatitis B virus infection. This research initiative will develop and implement...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Beckman Research Institute of the City of Hope a $177,992 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025, through August 31, 2027. The award supports the generation of novel tools and development of targeted approaches for AL (light-chain) amyloidosis, a serious protein misfolding disorder. Research activities will be conducted at the Institute's...
The Defense Health Agency (DHA) awarded Boston VA Research Institute, Inc. a $997,393 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026 through June 30, 2029. The research initiative, titled "Hemoglobin A1C Stability and Dementia in Older Adults with Diabetes," will investigate the relationship between glycemic control variability and cognitive decline in aging veterans with diabetes. This three-year project will deliver biomedical research and development services, including hypothesis-driven investigation, biomarker analysis, and clinical research findings designed to advance healthcare outcomes for military service members and the broader American public. As a non-profit research organization affiliated with VA Boston Healthcare System, Boston VA Research Institute will conduct the research at its Boston, Massachusetts location, leveraging institutional expertise in neuroscience and veterans' health research. The project aligns with DHA's priority focus on neurodegenerative disease biomarker development and represents a competitive award selected through the program's two-tier peer and programmatic review process, which emphasizes both technical merit and military relevance to advance innovative medical solutions addressing critical health challenges in the veteran population.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $997.4k | 4/20/26 |